MICHAEL JAMES: Open Payments
NPI 1659004430 · CARBONDALE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,606 in 162 payments from 21 companies in 2025. Trend: 2023 $1,540 · 2024 $3,365 · 2025 $4,606
Food & beverage: $4,498Education: $108
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 54 | $1,489 |
| Janssen Biotech, Inc. | 24 | $717 |
| Madrigal Pharmaceuticals | 11 | $556 |
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $282 |
| Gilead Sciences, Inc. | 9 | $249 |
| Ardelyx, Inc. | 9 | $233 |
| Ipsen Biopharmaceuticals, Inc | 3 | $199 |
| Exact Sciences Corporation | 6 | $173 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $152 |
| Phathom Pharmaceuticals, Inc. | 2 | $134 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, SKYRIZI, ENTYVIO, IBSRELA, IQIRVO, XIFAXAN.
Industry payments across IL — which companies pay providers there.
